Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | +34.05% | $47.31 | $63.42 | 2022-05-09 - 2023-05-09 | Buy |
Beam Therapeutics IncBEAM | +19.85% | $22.27 | $26.69 | 2023-10-16 - 2024-10-16 | Strong Buy |
Beam Therapeutics IncBEAM | +9.82% | $23.72 | $26.05 | 2023-08-28 - 2024-08-28 | Strong Buy |
Beam Therapeutics IncBEAM | +0.18% | $33.29 | $33.35 | 2022-05-08 - 2023-05-08 | Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Legend Biotech CorpLEGN | 2 | Strong Buy | $83.00 | +137.48% | Reiterates | 5 months ago |
Beam Therapeutics IncBEAM | 10 | Buy | $39.00 | +95.68% | Upgrades | 6 months ago |
Intellia Therapeutics IncNTLA | 7 | Strong Buy | $65.00 | +632.81% | Reiterates | 10 months ago |
Verve Therapeutics IncVERV | 3 | Hold | $22.00 | N/A | Reiterates | 2 years ago |
Editas Medicine IncEDIT | 6 | Strong Buy | $14.00 | N/A | Reiterates | 2 years ago |
Crispr Therapeutics AgCRSP | 4 | Buy | $107.00 | N/A | Maintains | 3 years ago |